Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1817759
Max Phase: Preclinical
Molecular Formula: C38H59N13O12S2
Molecular Weight: 954.10
Molecule Type: Protein
Associated Items:
ID: ALA1817759
Max Phase: Preclinical
Molecular Formula: C38H59N13O12S2
Molecular Weight: 954.10
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O
Standard InChI: InChI=1S/C38H59N13O12S2/c1-3-18(2)30-37(61)48-24(14-28(42)53)33(57)47-23(13-27(41)52)34(58)49-25(17-65-64-16-20(40)31(55)46-22(35(59)50-30)12-19-6-5-11-63-19)38(62)51-10-4-7-26(51)36(60)45-21(8-9-39)32(56)44-15-29(43)54/h5-6,11,18,20-26,30H,3-4,7-10,12-17,39-40H2,1-2H3,(H2,41,52)(H2,42,53)(H2,43,54)(H,44,56)(H,45,60)(H,46,55)(H,47,57)(H,48,61)(H,49,58)(H,50,59)/t18-,20-,21-,22-,23-,24-,25-,26-,30-/m0/s1
Standard InChI Key: GYGFTCDERGFHKB-URPKOMAESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 954.10 | Molecular Weight (Monoisotopic): 953.3848 | AlogP: -5.81 | #Rotatable Bonds: 16 |
Polar Surface Area: 418.46 | Molecular Species: BASE | HBA: 16 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 25 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.16 | CX Basic pKa: 9.53 | CX LogP: -8.36 | CX LogD: -10.90 |
Aromatic Rings: 1 | Heavy Atoms: 65 | QED Weighted: 0.07 | Np Likeness Score: 0.30 |
1. Wisniewski K, Galyean R, Tariga H, Alagarsamy S, Croston G, Heitzmann J, Kohan A, Wisniewska H, Laporte R, Rivière PJ, Schteingart CD.. (2011) New, potent, selective, and short-acting peptidic V1a receptor agonists., 54 (13): [PMID:21688787] [10.1021/jm200278m] |
Source(1):